Sunflower suspends trading for major asset restructuring

Zhejiang Sunflower Great Health Technology Co. (SZSE:300111) announced a trading suspension from September 8, 2025, due to a planned major asset restructuring. The company intends to acquire controlling stakes in Zhangzhou Xipu Materials Technology Co. and 40% of Zhejiang Beide Pharmaceutical Co. through share issuance and/or cash payments, along with raising supporting funds. The restructuring is expected to constitute a major asset reorganization and will not change the company's actual controller. The company anticipates disclosing a transaction plan by September 22, 2025.

In related news, on September 4, 2025, controlling shareholder Wu Jianlong released 50,000,000 pledged shares, reducing his pledged stake by 13.49% of his total holdings. Simultaneously, on September 5, 2025, Wu Jianlong pledged an additional 40,000,000 shares, representing 10.79% of his holdings, for his own production and business operations. Wu Jianlong’s cumulative pledged shares now total 281,000,000 shares, representing 75.82% of his holdings.